Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jan;74(1):39-42.
doi: 10.1007/s12098-007-0024-z.

Multidrug-resistant typhoid fever

Rajiv Kumar  1 , Nomeeta Gupta; Shalini
Affiliations
Randomized Controlled Trial

Multidrug-resistant typhoid fever

Rajiv Kumar et al. Indian J Pediatr. 2007 Jan.

Abstract

Objective: To study the epidemiological pattern, clinical picture, the recent trends of multidrug-resistant typhoid fever (MDRTF), and therapeutic response of ofloxacin and ceftriaxone in MDRTF.

Methods: The present prospective randomized controlled parallel study was conducted on 93 blood culture-proven Salmonella typhi children. All MDRTF cases were randomized to treatment with ofloxacin or ceftriaxone.

Results: Of 93 children, 62 (66.6%) were MDRTF. 24 cases were below 5 years, 26 between 5-10 years and 12 were above 10 years. Male to female ratio was 1.85: 1. Majority of cases came from lower middle socio-economic classes with poor personal hygiene. Fever was the main presenting symptom. Hepatomegaly and splenomegaly was present in 88% and 46% cases respectively. 19 (30.6%) cases developed complications. Mean defervescence time with ceftriaxone and ofloxacin was 4.258 and 4.968 days respectively.

Conclusion: MDRTF is still emerging as serious public and therapeutic challenge. Ceftriaxone is well-tolerated and effective drug but expensive whereas ofloxacin is safe, cost-effective and therapeutic alternative in treatment of MDRTF in children with comparable efficacy to ceftriaxone.

PubMed Disclaimer

References

    1. Indian Pediatr. 1994 Jul;31(7):813-9 - PubMed
    1. Pediatr Infect Dis. 1985 Sep-Oct;4(5):496-8 - PubMed
    1. Trop Doct. 2000 Oct;30(4):195-7 - PubMed
    1. Antimicrob Agents Chemother. 1994 Aug;38(8):1716-20 - PubMed
    1. Lancet. 1999 Aug 28;354(9180):734-7 - PubMed

Publication types

MeSH terms